Cargando…
Antipsychotic polypharmacy in adult patients diagnosed with schizophrenia: A retrospective study
Antipsychotic polypharmacy (APP) is a common practice in the treatment of schizophrenia. In this study, we aimed to identify the prevalence of APP in our department, as well as the trends associated with co-prescribing antipsychotics. We collected data from the medical records of all 193 inpatients...
Autores principales: | Patrichi, Bogdan, Ţăpoi, Cristiana, Rogojină, Radu Ştefan, Bedreagă, Irina, Dumitrache, Anca, Itu, Andreea, Dragomir, Radu, Buciuc, Adela-Georgiana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8438669/ https://www.ncbi.nlm.nih.gov/pubmed/34539821 http://dx.doi.org/10.3892/etm.2021.10659 |
Ejemplares similares
-
Functional Neurological Symptom Disorder In A Prolonged Grief Disorder Or In Depression?
por: Varlam, C.I., et al.
Publicado: (2022) -
Antipsychotic polypharmacy reduction versus polypharmacy continuation for people with schizophrenia
por: Bighelli, Irene, et al.
Publicado: (2022) -
Cost of antipsychotic polypharmacy in the treatment of schizophrenia
por: Zhu, Baojin, et al.
Publicado: (2008) -
Polypharmacy Management of Antipsychotics in Patients with Schizophrenia
por: Kamei, Hiroyuki
Publicado: (2022) -
Antipsychotic monotherapy and polypharmacy in the naturalistic treatment of schizophrenia with atypical antipsychotics
por: Faries, Douglas, et al.
Publicado: (2005)